Código QR (código de barras bidimensional)

The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson’s disease

Background: NICE in England, and ICER in the US both use cost-utility analyses (CUA) and budget impact analyses (BIA) to assess value for money and affordability, however the thresholds used differ greatly. Objective: To perform a cross-country comparison of the results of the CUA and BIA and detail...

ver descrição completa

Na minha lista:
Principais autores: Jesper Jørgensen, Spiros Servos, Panos Kefalas
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2018-01-01
coleção:Journal of Market Access & Health Policy
Assuntos:
Gene therapy
Parkinson’s disease
cost-utility analysis
budget impact analysis
pricing and reimbursement
patient access
England
United Kingdom (UK)
Acesso em linha:http://dx.doi.org/10.1080/20016689.2018.1500419
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados